State of New Jersey Common Pension Fund D’s BioMarin Pharmaceuticals BMRN Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.29M	Sell	57,522 -4,852	-8%	-$266K	0.01%	758
2026 Q1	$3.52M	Sell	62,374 -1,096	-2%	-$63.9K	0.01%	705
2025 Q4	$3.77M	Sell	63,470 -3,855	-6%	-$210K	0.01%	683
2025 Q3	$3.65M	Buy	67,325 +4,049	+6%	+$232K	0.01%	687
2025 Q2	$3.48M	Hold	63,276	–	–	0.01%	677
2025 Q1	$4.47M	Sell	63,276 -5,127	-7%	-$345K	0.02%	563
2024 Q4	$4.5M	Hold	68,403	–	–	0.02%	607
2024 Q3	$4.81M	Hold	68,403	–	–	0.02%	588
2024 Q2	$5.63M	Sell	68,403 -37,718	-36%	-$3.14M	0.02%	511
2024 Q1	$9.27M	Sell	106,121 -2,380	-2%	-$213K	0.03%	498
2023 Q4	$10.5M	Hold	108,501	–	–	0.04%	421
2023 Q3	$9.6M	Sell	108,501 -3,180	-3%	-$283K	0.03%	423
2023 Q2	$9.68M	Buy	111,681 +2,782	+3%	+$262K	0.03%	445
2023 Q1	$10.6M	Hold	108,899	–	–	0.04%	416
2022 Q4	$11.3M	Hold	108,899	–	–	0.04%	395
2022 Q3	$9.23M	Hold	108,899	–	–	0.04%	421
2022 Q2	$9.02M	Hold	108,899	–	–	0.03%	443
2022 Q1	$8.4M	Sell	108,899 -3,015	-3%	-$252K	0.03%	545
2021 Q4	$9.89M	Buy	111,914 +3,272	+3%	+$270K	0.03%	508
2021 Q3	$8.4M	Buy	108,642 +1,209	+1%	+$95.4K	0.03%	553
2021 Q2	$8.96M	Sell	107,433 -4,686	-4%	-$371K	0.03%	532
2021 Q1	$8.47M	Sell	112,119 -6,909	-6%	-$564K	0.03%	539
2020 Q4	$10.4M	Sell	119,028 -7,710	-6%	-$611K	0.04%	434
2020 Q3	$9.64M	Sell	126,738 -2,268	-2%	-$229K	0.04%	421
2020 Q2	$15.9M	Sell	129,006 -6,190	-5%	-$615K	0.07%	285
2020 Q1	$11.4M	Hold	135,196	–	–	0.06%	325
2019 Q4	$11.4M	Sell	135,196 -8,604	-6%	-$650K	0.04%	407
2019 Q3	$9.69M	Buy	+143,800	New	+$11.1M	0.04%	475

Other funds holding BMRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AIM

ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State of New Jersey Common Pension Fund D's BMRN Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its BioMarin Pharmaceuticals (BMRN) stake by 7.8% in Q2 2026, selling an estimated $266K and leaving 57,522 shares worth $3.29M. The position accounts for 0.01% of the portfolio, ranked #758.

State of New Jersey Common Pension Fund D first reported a position in BMRN in Q3 2019 and has held it in 28 quarters since. The position peaked at $15.9M in Q2 2020. 257 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

State of New Jersey Common Pension Fund D held 57,522 shares of BioMarin Pharmaceuticals worth $3.29M as of Q2 2026.
State of New Jersey Common Pension Fund D sold 4,852 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $266K.
BioMarin Pharmaceuticals made up 0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #758 holding.
State of New Jersey Common Pension Fund D first reported a position in BioMarin Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
State of New Jersey Common Pension Fund D's BioMarin Pharmaceuticals position peaked at $15.9M in Q2 2020.
257 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.